A new single-cell profiling technique has mapped pre-malignant gene mutations and their effects in solid tissues for the ...

Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies.

Synthetic lethality may help overcome cancer therapeutic resistance by exploiting tumour vulnerabilities, supported by ...

Marissa Sulek joined CBS News Chicago in January 2025. Before Chicago, Marissa was a general assignment reporter in Nashville at WSMV, where she was nominated for Mid-South Emmy Awards for her ...

KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...

Among modern cancer therapies, immune checkpoint inhibitors (ICI) are among the most successful treatment methods. These ...

Cancer immunotherapy is a strategy that turns the patient’s own immune cells into a “search-and-destroy” force that attacks the tumor’s cells. The “search” immune cells are the dendritic cells, which ...

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

Stanford University-led researchers report that tumor cells hijack mitochondria from immune cells, reducing anti-tumor immune ...

Several specific genetic mutations have been associated with colorectal cancer (CRC) and dysplasia in patients with ulcerative colitis (UC). [1] Many of these genetic alterations are unique to ...

“The association between fat accumulation, cancer aggressiveness and poor patient outcomes has been identified for decades in breast and other cancers,” Andolino said. “But how those fats accumulate ...